Literature DB >> 1375324

The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.

Z Kozmik1, S Wang, P Dörfler, B Adams, M Busslinger.   

Abstract

The CD19 protein is expressed on the surface of all B-lymphoid cells with the exception of terminally differentiated plasma cells and has been implicated as a signal-transducing receptor in the control of proliferation and differentiation. Here we demonstrate complete correlation between the expression pattern of the CD19 gene and the B-cell-specific transcription factor BSAP in a large panel of B-lymphoid cell lines. The human CD19 gene has been cloned, and several BSAP-binding sites have been mapped by in vitro protein-DNA binding studies. In particular, a high-affinity BSAP-binding site instead of a TATA sequence is located in the -30 promoter region upstream of a cluster of heterogeneous transcription start sites. Moreover, this site is occupied by BSAP in vivo in a CD19-expressing B-cell line but not in plasma or HeLa cells. This high-affinity site has been conserved in the promoters of both human and mouse CD19 genes and was furthermore shown to confer B-cell specificity to a beta-globin reporter gene in transient transfection experiments. In addition, BSAP was found to be the only abundant DNA-binding activity of B-cell nuclear extracts that interacts with the CD19 promoter. Together, this evidence strongly implicates BSAP in the regulation of the CD19 gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375324      PMCID: PMC364460          DOI: 10.1128/mcb.12.6.2662-2672.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.

Authors:  E Nakayama; I von Hoegen; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.

Authors:  J T Golay; D H Crawford
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Cloning of the shark Po promoter using a genomic walking technique based on the polymerase chain reaction.

Authors:  L Fors; R A Saavedra; L Hood
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

4.  Immunoglobulin enhancer and promoter motifs 5' of the B29 B-cell-specific gene.

Authors:  G G Hermanson; M Briskin; D Sigman; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19.

Authors:  J A Ledbetter; P S Rabinovitch; C H June; C W Song; E A Clark; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Developmental and tissue-specific regulation of a novel transcription factor of the sea urchin.

Authors:  A Barberis; G Superti-Furga; L Vitelli; I Kemler; M Busslinger
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

8.  A family of cosmid vectors with the multi-copy R6K replication origin.

Authors:  E Ehrich; A Craig; A Poustka; A M Frischauf; H Lehrach
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins.

Authors:  F M Uckun; W Jaszcz; J L Ambrus; A S Fauci; K Gajl-Peczalska; C W Song; M R Wick; D E Myers; K Waddick; J A Ledbetter
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

10.  B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties.

Authors:  N Sakaguchi; S Kashiwamura; M Kimoto; P Thalmann; F Melchers
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  79 in total

Review 1.  Review article: role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.

Authors:  I L Mårtensson; R Ceredig
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site.

Authors:  Holly Maier; Jeff Colbert; Daniel Fitzsimmons; Dawn R Clark; James Hagman
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment.

Authors:  Melissa L Holmes; Sebastian Carotta; Lynn M Corcoran; Stephen L Nutt
Journal:  Genes Dev       Date:  2006-04-15       Impact factor: 11.361

5.  Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.

Authors:  M Busslinger; N Klix; P Pfeffer; P G Graninger; Z Kozmik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

7.  NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation.

Authors:  M Singh; B K Birshtein
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Purification of early-B-cell factor and characterization of its DNA-binding specificity.

Authors:  A Travis; J Hagman; L Hwang; R Grosschedl
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 9.  Transcriptional regulation of early B cell development.

Authors:  Daniel L Northrup; David Allman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.